Welcome to LookChem.com Sign In|Join Free
  • or
TRIFLUOROMETHIONINE is an L-alpha-amino acid, methionine, with the S-methyl group trifluoro-substituted. It is a modified form of the naturally occurring amino acid methionine, where three fluorine atoms replace the hydrogen atoms on the sulfur atom.

764-52-3

Post Buying Request

764-52-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

764-52-3 Usage

Uses

Used in Pharmaceutical Industry:
TRIFLUOROMETHIONINE is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its unique trifluoromethyl group provides specific properties that can enhance the activity and selectivity of the final drug product.
Used in Chemical Synthesis:
TRIFLUOROMETHIONINE is used as a building block in the synthesis of complex organic molecules and compounds. Its trifluoromethyl group can impart unique reactivity and stability to the synthesized products, making it a valuable component in organic chemistry.
Used in Biochemical Research:
TRIFLUOROMETHIONINE is used as a research tool in biochemical studies to investigate the role of methionine and its derivatives in various biological processes. Its trifluoromethyl group can provide insights into the effects of fluorination on protein structure, function, and stability.
Used in Agrochemical Industry:
TRIFLUOROMETHIONINE can be used as a precursor in the synthesis of agrochemicals, such as herbicides, insecticides, and fungicides. Its unique properties can contribute to the development of more effective and environmentally friendly agrochemical products.

Check Digit Verification of cas no

The CAS Registry Mumber 764-52-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,6 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 764-52:
(5*7)+(4*6)+(3*4)+(2*5)+(1*2)=83
83 % 10 = 3
So 764-52-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H8F3NO2S/c6-5(7,8)12-2-1-3(9)4(10)11/h3H,1-2,9H2,(H,10,11)/t3-/m0/s1

764-52-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-amino-4-(trifluoromethylsulfanyl)butanoic acid

1.2 Other means of identification

Product number -
Other names Trifluoromethionine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:764-52-3 SDS

764-52-3Synthetic route

iodotrifluoromethane
2314-97-8

iodotrifluoromethane

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

Conditions
ConditionsYield
Stage #1: L-homocystine With ammonia; sodium at -78 - 35℃; Birch Reduction; Inert atmosphere;
Stage #2: iodotrifluoromethane at -78℃; for 0.333333h;
93%
Stage #1: L-homocystine With sodium In ammonia at -78℃; liquid NH3;
Stage #2: iodotrifluoromethane In ammonia at -78℃; for 0.333333h; liquid NH3;
93%
N-acetyltrifluoromethylhomocysteine

N-acetyltrifluoromethylhomocysteine

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

Conditions
ConditionsYield
With pig liver acylase pH=7.2;26%
(S)-2-amino-N-phenyl-4-(trifluoromethylthio)butanamide hydrochloride
943925-89-1

(S)-2-amino-N-phenyl-4-(trifluoromethylthio)butanamide hydrochloride

A

aniline
62-53-3

aniline

B

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; water at 37℃; for 2h; Enzymatic reaction;
N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

Fmoc-S-trifluoromethionine

Fmoc-S-trifluoromethionine

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; acetone94%
C25H26N2O2
1445869-56-6

C25H26N2O2

nickel(II) acetate tetrahydrate
6018-89-9

nickel(II) acetate tetrahydrate

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

C30H30F3N3NiO3S

C30H30F3N3NiO3S

Conditions
ConditionsYield
With potassium carbonate In ethanol at 60 - 70℃;90%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

N-Boc-S-trifluoromethyl-L-homocysteine
201870-90-8

N-Boc-S-trifluoromethyl-L-homocysteine

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; water at 0℃;85%
With sodium hydroxide In 1,4-dioxane at 20℃; for 27h; Cooling with ice;39%
(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

For-homoCys(S-CF3)-Leu-Phe-OH
143673-81-8

For-homoCys(S-CF3)-Leu-Phe-OH

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 85 percent / NEt3 / tetrahydrofuran; H2O / 0 °C
2: 55 percent / HOBt, DCC / CH2Cl2; dimethylformamide / 0 deg C, 1 h, 23 deg C, 12 h
3: 2.) N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline / 1.) 23 deg C, 3 h, 2.) CHCl3, 23 deg C, 3 h
4: 95 percent / aq. NaOH / dioxane / 0 - 23 °C
View Scheme
(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

(S)-2-[(S)-2-((S)-2-Formylamino-4-trifluoromethylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester
201870-94-2

(S)-2-[(S)-2-((S)-2-Formylamino-4-trifluoromethylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 85 percent / NEt3 / tetrahydrofuran; H2O / 0 °C
2: 55 percent / HOBt, DCC / CH2Cl2; dimethylformamide / 0 deg C, 1 h, 23 deg C, 12 h
3: 2.) N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline / 1.) 23 deg C, 3 h, 2.) CHCl3, 23 deg C, 3 h
View Scheme
(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

(S)-2-[(S)-2-((S)-2-tert-Butoxycarbonylamino-4-trifluoromethylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester
201870-92-0

(S)-2-[(S)-2-((S)-2-tert-Butoxycarbonylamino-4-trifluoromethylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / NEt3 / tetrahydrofuran; H2O / 0 °C
2: 55 percent / HOBt, DCC / CH2Cl2; dimethylformamide / 0 deg C, 1 h, 23 deg C, 12 h
View Scheme
(S)-2-amino-4-(trifluoromethylthio)butanoic
764-52-3

(S)-2-amino-4-(trifluoromethylthio)butanoic

A

2-Oxobutyric acid
600-18-0

2-Oxobutyric acid

B

trifluoromethylsulfide
1493-15-8

trifluoromethylsulfide

Conditions
ConditionsYield
With 5,5'-dithiobis-(2-nitrobenzoic acid); recombinant Entamoeba histolytica L-methionine γ-lyase 2; pyridoxal 5'-phosphate; water at 37℃; pH=7.2; Kinetics; Reagent/catalyst; Time; aq. phosphate buffer; Enzymatic reaction;

764-52-3Relevant academic research and scientific papers

Robust synthesis of trifluoromethionine and its derivatives by reductive trifluoromethylation of amino acid disulfides by CF3I/Na/Liq.NH 3 system

Yasui, Hiroyuki,Yamamoto, Takeshi,Tokunaga, Etsuko,Shibata, Norio

, p. 186 - 189 (2011)

We disclose the reductive trifluoromethylation of chemically stable homocystine and cystine to provide corresponding trifluoromethyl ethers by the CF3I/Na/Liq.NH3 system. Both non-protected and protected homocystines can be nicely converted into trifluoromethylated methionines under the same condition. The method described offers a robust synthesis of pharmaceutically important trifluoromethionine, suitable for multigram synthesis. Pentafluoroethylation of homocystine was also achieved by the CF 3CF2I/Na/Liq.NH3 system.

Facile Synthesis of Fluorinated Methionines

Houston, Michael E.,Honek, John F.

, p. 761 - 762 (1989)

L-Di- and tri-fluoromethylhomocysteines (6) and (7) were efficiently prepared from N-acetylhomocystein thiolactone (3) and the protected monofluoromethylhomocysteine (2) was synthesized from the protected methionine sulphoxide (1).

Simple preparation of trifluoromethionine and derivatives thereof

-

Page/Page column 4, (2011/02/18)

Disclosed is a process for the simple preparation of trifluoromethionine, its analogs trifluoromethylcysteine, fluoroalkylhomocysteines, and fluoroalkylcysteines, and derivatives of them. These compounds are drug-candidate compounds or raw materials of drug-candidate compounds. Specifically, trifluoromethionine, trifluoromethylcysteine, a fluoroalkylhomocysteine, or a fluoroalkylcysteine is simply and conveniently prepared directly without passing through homocysteine or cysteine by adding metallic sodium to an optically active or racemic homocystine or cystine in liquid ammonia and further adding a fluoroalkyl iodide thereto under Birch reduction conditions.

Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica

Sato, Dan,Kobayashi, Seiki,Yasui, Hiroyuki,Shibata, Norio,Toru, Takeshi,Yamamoto, Masaichi,Tokoro, Gensuke,Ali, Vahab,Soga, Tomoyoshi,Takeuchi, Tsutomu,Suematsu, Makoto,Nozaki, Tomoyoshi

experimental part, p. 56 - 61 (2012/01/04)

Amoebiasis, caused by infection with the enteric protist Entamoeba histolytica, is one of the major parasitic diseases. Although metronidazole and its derivatives are currently employed in therapy, the paucity of effective drugs and potential clinical resistance necessitate the development of a novel drug. Trifluoromethionine (TFM) is a promising lead compound for antiamoebic drugs. To potentiate the antiamoebic effect of TFM, we synthesised various amide derivatives of TFM and evaluated their cytotoxicity. The amide derivatives of TFM were observed to have a superior cytotoxic effect compared with TFM and metronidazole against E. histolytica in vitro. Although TFM showed cytotoxicity following degradation by methionine γ-lyase, the derivatives were degraded by the enzyme less efficiently compared with TFM. We further demonstrated that a representative derivative was hydrolysed by the amoebic cell lysate to first yield TFM, followed by degradation similar to TFM. Hydrolysis was partially inhibited by protease inhibitors. A single subcutaneous or oral administration of TFM and its amide derivatives also effectively prevented the formation of amoebic liver abscess in a rodent model. These data demonstrate the improved effectiveness of TFM derivatives against E. histolytica infection and elucidate the mechanisms underlining the mode of action of these compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 764-52-3